Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
Position
Chief Financial Officer
Company
Cencora
ConshohockenBiotechnologyHealth CarePharmaceuticalDescription
Cencora, Inc. has announced the appointment of Eva C. Boratto as Executive Vice President and Chief Financial Officer, effective June 29, 2026
Other recent leadership changes in Pharmaceutical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- Igor Bluvstein Appointed Chief Financial Officer at REVIUM Rx (June 1, 2026)
- VistaGen Therapeutics Appoints Angel S. Angelov as Chief Medical Officer (May 20, 2026)
- Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (May 19, 2026)
- AFT Pharmaceuticals Appoints Stuart Houliston as Chief Financial Officer (May 18, 2026)
- AbCellera Biologics Inc. Appoints Victor Sandor as Director (June 5, 2026)
Who to call at Cencora, and when
A new leader at Cencora brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cencora raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cencora, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cencora. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cencora changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cencora changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.